Abbrea Capital LLC Sells 5,320 Shares of Bristol-Myers Squibb (NYSE:BMY)
The Cerbat Gem - 2024-04-25T18:00:52.000Z

Abbrea Capital LLC reduced its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 47.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,844 shares of the biopharmaceutical company’s stock after selling 5,320 shares during the quarter. Abbrea Capital LLC’s […] Read this story